Crinetics Pharmaceuticals
CRNX
CRNX
234 hedge funds and large institutions have $3.69B invested in Crinetics Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 103 increasing their positions, 57 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.4% more ownership
Funds ownership: 103.2% → 104.6% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 13 → 13 (0)
2% less capital invested
Capital invested by funds: $3.76B → $3.69B (-$68.7M)
Holders
234
Holding in Top 10
13
Calls
$13.5M
Puts
$8.82M
Top Buyers
| 1 | +$73.9M | |
| 2 | +$42.1M | |
| 3 | +$39.7M | |
| 4 |
BlackRock
New York
|
+$35.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.1M |
Top Sellers
| 1 | -$97.1M | |
| 2 | -$58.6M | |
| 3 | -$27.4M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$21.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$19.8M |